Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes
详细信息 查看全文
- 作者：B. D. Modena ; S. M. Kurian ; L. W. Gaber ; J. Waalen ; A. I. Su ; T. Gelbart ; T. S. Mondala ; S. R. Head ; S. Papp ; R. Heilman ; J. J. Friedewald ; S. M. Flechner ; C. L. Marsh ; R. S. Sung ; H. Shidban ; L. Chan ; M. M. Abecassis and D. R. Salomon
- 刊名：American Journal of Transplantation
- 出版年：2016
- 出版时间：July 2016
- 年：2016
- 卷：16
- 期：7
- 页码：1982-1998
- 全文大小：1427K
- ISSN：1600-6143
文摘
Interstitial fibrosis and tubular atrophy (IFTA) is found in approximately 25% of 1-year biopsies posttransplant. It is known that IFTA correlates with decreased graft survival when histological evidence of inflammation is present. Identifying the mechanistic etiology of IFTA is important to understanding why long-term graft survival has not changed as expected despite improved immunosuppression and dramatically reduced rates of clinical acute rejection (AR) (Services UDoHaH. http://www.ustransplant.org/annual_reports/current/509a_ki.htm). Gene expression profiles of 234 graft biopsy samples were obtained with matching clinical and outcome data. Eighty-one IFTA biopsies were divided into subphenotypes by degree of histological inflammation: IFTA with AR, IFTA with inflammation, and IFTA without inflammation. Samples with AR (n = 54) and normally functioning transplants (TX; n = 99) were used in comparisons. A novel analysis using gene coexpression networks revealed that all IFTA phenotypes were strongly enriched for dysregulated gene pathways and these were shared with the biopsy profiles of AR, including IFTA samples without histological evidence of inflammation. Thus, by molecular profiling we demonstrate that most IFTA samples have ongoing immune-mediated injury or chronic rejection that is more sensitively detected by gene expression profiling. These molecular biopsy profiles correlated with future graft loss in IFTA samples without inflammation.